Whole-body cryotherapy (WBC) has been frequently used to supplement the rehabilitation of patients with rheumatoid arthritis (RA). The aim of this study was to compare the effect of WBC and traditional rehabilitation (TR) on clinical parameters and systemic levels of IL-6, TNF-αin patients with RA. The study group comprised 25 patients who were subjected to WBC (−110°C) and 19 patients who underwent a traditional rehabilitation program. Some clinical variables and levels of interleukin-6 (IL-6) and tumor necrosis factor-α(TNF-α) were used to assess the outcomes. After therapy both groups exhibited similar improvement in pain, disease activity, fatigue, time of walking, and the number of steps over a distance of 50 m. Only significantly better results were observed in HAQ in TR group (p< 0.05). However, similar significant reduction in IL-6 and TNF-αlevel was observed. The results showed positive effects of a 2-week rehabilitation program for patients with RA regardless of the kind of the applied physical procedure.

Purpose. Patients with ankylosing spondylitis (AS) have increased production of proinflammatory cytokines, increased oxidants, and decreased antioxidant capacity. The aim of this study was to determine the effect of whole‐body cryotherapy (WBC) at −110°C and −60°C, on disease activity, selected proinflammatory cytokines, and oxidative stress in patients with AS. Methods. Sixty‐five patients with AS were recruited to one of three study procedures: WBC at −110°C, −60°C, or exercise therapy (non‐WBC). The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score (ASDAS‐CRP), concentration of C‐reactive protein (CRP), and the concentrations of interleukin 8 and 17 (IL‐8, IL‐17) were measured at the beginning of the study and at the end of the intervention. The concentration of thiobarbituric acid reactive substances (TBARS), as a lipid peroxidation result, and total antioxidant status, an antioxidant organism potential, were measured. Results. All the studied groups showed significantly decreased posttherapy disease activity expressed as a function of the BASDAI, ASDAS‐CRP, and the IL‐8 concentration. We found that the TBARS concentration after therapy was significantly increased in the WBC at −110°C group. A comparison of the therapeutic effects between the treatment groups showed a significantly lower BASDAI after therapy in the WBC at −110°C group compared to the non‐WBC group. Conclusion. WBC at −110°C had a positive effect on lowering AS clinical activity as measured by the BASDAI.

We evaluated areal bone mineral density (aBMD), bone mineral content (BMC), and markers of bone turnover in male competitive masters athletes representing different training profile in the past and at present, aged 40-64 (14 endurance runners, and 12 speed-power athletes), and non-sport controls (n = 13). Dual-energy X-ray absorptiometry measurements of total body and regional aBMD, BMC and soft tissue composition were acquired. Serum concentrations of osteocalcin (OC), C-terminal crosslinking telopeptide of type I collagen (CTX), tumour necrosis factor-alpha (TNF-alpha), total testosterone (TT), free testosterone (FT) and insulin like growth factor-1 (IGF-1) were measured. Adjusted total and regional aBMD and BMC (covariates: body mass, body height and age) were significantly greater in all measured regions in speed-power athletes than in endurance athletes and control subjects, but adjusted aBMD and BMC values were not significantly different between endurance athletes and controls. No differences in bone formation (OC), bone resorption (CTX), and serum concentrations of TNF-alpha, TT, FT and IGF-1 were noted. This suggests that weight-bearing exercise in young age and the training continuation in later life may be an important contributor to the aBMD and BMC in the middle age and in the elderly. It seems also that training-related bone differences in men are not caused by present alterations in bone turn-over or somatotropic effects. However, conclusions must be drawn with caution due to a large variability of biochemical markers.

The study reports the development of a thermal imaging method suitable for the screening and differentiation of joint inflammation in the rheumatoid foot of patients in comparison with the control group of healthy participants. The study included 81 patients, with rheumatoid arthritis (RA), and 39 healthy volunteers without any signs or symptoms of inflammation. The feet joints were examined by ultrasonography, and the surface temperature of the dorsal side of the foot was measured using a thermovision camera. Significant differences in mean temperatures between the study group and the control group were found. At the same time, there were no statistically significant differences between the mean temperatures in the left and right foot in any of the designated regions in the study and control group. The comparison of average temperatures of joints with or without inflammation, according to ultrasonography, did not show significance except for two joints. Despite the lack of statistical differences in the recorded temperatures, changes in the form of spikes, hot spots, and gradation of the temperatures during screening were observed. Screening analysis of the temperature distribution of the foot can aid in the diagnosis of RA and in the evaluation of the development of the disease. Additional studies must be conducted to confirm the results of this study.

BACKGROUND: The treatment of ankylosing spondylitis (AS) patients requires a combination of non-pharmacological (education, exercise and physical therapy), as well as pharmacological treatment modalities. The optimal management of AS still remains un